Educational guide
Homepage - GEN - Genetic Engineering and Biotechnology News
Next 10 U.S. Biopharma Clusters For the first time, GEN‘s Alex Philippidis examines the top regions and top states just below the 10 largest regions for life sciences activity, as the field looks beyond the East and West Coasts for growth. Thanks to booming sa
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Next 10 U.S. Biopharma Clusters
For the first time, GEN‘s Alex Philippidis examines the top regions and top states just below the 10 largest regions for life sciences activity, as the field looks beyond the East and West Coasts for growth.
Thanks to booming sales of blockbuster obesity and diabetes treatments, the amount that Americans spent on prescription drugs this year is on track to surpass $1 trillion. Total aggregate value of the drugs generating the highest sales in 2025 jumped 21.5% vs. 2024, and more than doubled from a decade ago.
Mid-cap buyers, improved capital raising climate, and reshoring of manufacturing are shaping how much and where biopharmas choose to grow.
What are the best-selling gene therapies on the market? It probably comes as no surprise that Luxturna, Casgevy, and Zolgensma are on the list. But what is number 1? Check out the list to find out.
Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.
Wednesday’s episode of GEN Live will explore the rapidly evolving field of AAV gene therapy. Leaders from clinical and translational research will discuss current advances and challenges in AAV vector development, delivery, safety, and long-term therapeutic efficacy.
The Perelman School of Medicine
University of Pennsylvania
Director, Clinical In Vivo Gene Therapy
Children’s Hospital of Philadelphia
Co-Director, Gene Therapy Program
Director, Viral Vector Facility
University of Texas Southwestern Medical Center
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what’s now and next. Start listening today!
Stay up to date with the lasted episodes of Touching Base by subscribing to the GEN Podcast Newsletter
Bioprocessing
BMS Chooses Houston for $2.3B Manufacturing Facility
Translational Medicine
StockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss
Artificial Intelligence